Browse

The planned acquisition of Kartos Therapeutics would hand Ipsen a late-stage asset for myelofibrosis. Elsewhere, Sobi hit a regulatory setback and BeOne unveiled more positive Brukinsa data.

Depression, the New Jersey congressman said, “is physical, it is emotional, and until you experience it yourself, it is difficult to fully understand how powerful this illness can be.”

Anthropic released Claude Science, an application that optimizes its large language model for scientists and, especially, those doing research at pharma companies.